skip to main content


ACI 23rd Drug & Medical Device Litigation

November 28-30, 2018

Speakers: Robert R. Simpson

November 28-30, 2018

New York Marriott Marquis
1535 Broadway
New York, NY 10036

Robert Simpson and co-presenters Sonia Chen Arnold of Eli Lilly and Company, Rachel Gallagher of Teva Pharmaceuticals USA, Inc. and Kim M. Schmid of Bowman and Brooke LLP will present the session "Practical Ways for Incorporating Diversity and Inclusion into Your Trial Team and Litigation Strategy" during ACI's 23rd Drug & Medical Device Litigation event.

 In this session, points of discussion will include:

  • Making sure all understand why it makes good business sense to have a diverse litigation team within both companies and law firms
  • Moving from an intellectual understanding of the need for diversity to measurable efforts showing recruitment, retention, and advancement
    • Discussing what diversity initiatives are working and designing sustainable diversity program for life sciences companies and outside law firms representing them
  • How law firms and companies can best implement policies that will truly effect change and promote a diverse workforce
    • What specific evidence of diversity are companies seeking from outside counsel
      • Firm composition overall
      • Partners
      • Breakdowns within teams
  • Evaluating a firm’s efforts in promoting diversity
    • Having a written plan and timeline in place to measure diversity efforts
    • Targeting specific deficiencies within the firm’s composition
    • Putting together a leadership team to develop and mentor diverse talent

For more information or to register for this event, please click here.

© Shipman & Goodwin LLP, 2019. All Rights Reserved.